| Date Filed | Type | Description |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/05/2023 |
4
| Hosseinion Warren (President) has filed a Form 4 on Nutex Health, Inc.|
Txns:
| Gifted 141,000 shares
@ $0
Gifted 50,000 options to buy
@ $1.5, valued at
$75k
Gifted 10,795 warrants
@ $6.67, valued at
$72k
|
|
| 09/26/2023 |
SC 13G/A
| Premier Macy Management Holdings, LLC reports a 5% stake in NUTEX HEALTH INC. |
| 08/23/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/07/2023 |
SC 13G
| Premier Macy Management Holdings, LLC reports a 6.3% stake in NUTEX HEALTH INC. |
| 07/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/16/2023 |
4
| Grenas Cheryl Yvonne (Director) has filed a Form 4 on Nutex Health, Inc.|
Txns:
| Bought 10,000 shares
@ $0.43, valued at
$4.3k
|
|
| 05/26/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/19/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/19/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/18/2023 |
4
| Waters John J (Director) has filed a Form 4 on Nutex Health, Inc.|
Txns:
| Bought 50,000 shares
@ $0.469, valued at
$23.5k
|
|
| 05/15/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
3
| Stites Danniel (Director) has filed a Form 3 on Nutex Health, Inc. |
| 05/11/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/09/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/06/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/27/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/10/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/02/2023 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits Interactive Data |
| 03/02/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 01/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/21/2022 |
8-K
| Quarterly results |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
8-K
| Quarterly results |
| 11/21/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"THE COMPANY:",
"REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT , dated as of November 14, 2022, is made by and between NUTEX HEALTH INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof . WHEREAS: The Company has the right, upon the terms and subject to the conditions of the Purchase Agreement, to sell and issue to the Buyer up to One Hundred Million Dollars of Purchase Shares and to induce the Buyer to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended..." |
|
|